RWA Wealth Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$706K Sell
2,523
-10
-0.4% -$2.63K 0.01% 409
2026
Q1
$676K Buy
2,533
+1
+0% +$271 0.01% 404
2025
Q4
$635K Buy
2,532
+15
+0.6% +$3.98K 0.01% 403
2025
Q3
$723K Buy
2,517
+7
+0.3% +$1.88K 0.01% 386
2025
Q2
$659K Buy
2,510
+10
+0.4% +$2.44K 0.01% 385
2025
Q1
$582K Sell
2,500
-288
-10% -$69.9K 0.01% 389
2024
Q4
$639K Sell
2,788
-167
-6% -$38.3K 0.01% 386
2024
Q3
$660K Sell
2,955
-3
-0.1% -$659 0.01% 374
2024
Q2
$602K Sell
2,958
-113
-4% -$23K 0.01% 372
2024
Q1
$671K Sell
3,071
-20
-0.6% -$4.41K 0.01% 354
2023
Q4
$703K Buy
3,091
+525
+20% +$110K 0.01% 338
2023
Q3
$516K Buy
2,566
+1,092
+74% +$230K 0.01% 261
2023
Q2
$306K Buy
+1,474
New +$286K 0.01% 272
2018
Q3
Sell
-233
Closed -$36K 503
2018
Q2
$36K Sell
233
-85
-27% -$12.8K ﹤0.01% 461
2018
Q1
$44K Buy
+318
New +$46.7K 0.01% 354

Other funds holding LH

RWA Wealth Partners's LH Position: Q2 2026 in Review

RWA Wealth Partners reduced its Labcorp (LH) stake by 0.39% in Q2 2026, selling an estimated $2.63K and leaving 2,523 shares worth $706K. The position accounts for 0.01% of the portfolio, ranked #409.

RWA Wealth Partners first reported a position in LH in Q1 2018 and has held it in 15 quarters since. The position peaked at $723K in Q3 2025. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • RWA Wealth Partners held 2,523 shares of Labcorp worth $706K as of Q2 2026.
  • RWA Wealth Partners sold 10 Labcorp shares in Q2 2026, an estimated $2.63K.
  • Labcorp made up 0.01% of RWA Wealth Partners's portfolio in Q2 2026, its #409 holding.
  • RWA Wealth Partners first reported a position in Labcorp in Q1 2018 and has held it in 15 quarters since.
  • RWA Wealth Partners's Labcorp position peaked at $723K in Q3 2025.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.